JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 6 1083-1087
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mills, B. G.
Right arrow Articles by Waxman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mills, B. G.
Right arrow Articles by Waxman, A. D.

Gallium-67 Citrate Localization in Osteoclast Nuclei of Paget's Disease of Bone

Barbara G. Mills, Laurence S. Masuoka, Clarence C. Graham, Jr., Frederick R. Singer and Alan D. Waxman

Departments of Basic Sciences, Medicine and Nuclear Medicine, University of Southern California and Orthopaedic Hospital, Los Angeles, California

Correspondence: For reprints contact: Barbara G. Mills, MD, Bone Physiology Laboratory, Orthopaedic Hospital, 2400 South Flower St., Los Angeles, CA 90007-2697.

ABSTRACT

Gallium-67 citrate scintigraphy has been used to indicate the extent of bone involvement in patients with Paget's disease of bone and is an excellent marker in monitoring the effects of specific therapy. Since gallium uptake is dependent on cellular function, autoradiographic techniques can be applied to cells of Paget's lesions to understand better the mechanism of [67Ga]citrate uptake. Bone biopsies were obtained from sites of increased uptake using [67Ga]citrate scintigraphy in two patients with Paget's disease. In both patients electron microscopic autoradiographs demonstrated a high concentration of silver grains over the nuclei of osteoclasts. The cellular mechanism is unknown but may be related to the known inhibitory effect of calcitonin on osteoclast activity. The association of [67Ga]citrate with the nucleus of the osteoclasts is unique and different from tumor cells in which there is a high association of [67Ga]citrate with the lysosome fraction within the cytoplasm.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
L. R. Bernstein
Mechanisms of Therapeutic Activity for Gallium
Pharmacol. Rev., December 1, 1998; 50(4): 665 - 682.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.